ANCOBON PRESCRIBING INFORMATION PDF

0 Comments

Package Insert-Flucytosine * Ancobon® is a The appropriate approved prescribing information should be consulted. Images. Group: antifungal. Capsule, mg [EDL] Solution for injection, g in ml [ EDL]. General information. Flucytosine is a fluorinated pyrimidine, non-antibiotic . Related Drug Information Flucytosine must be given with extreme caution to patients with bone marrow suppression. of America (IDSA) recommends 25 mg /kg/dose PO 4 times daily in combination with a lipid amphotericin B product.

Author: Maugor Shaktikinos
Country: French Guiana
Language: English (Spanish)
Genre: Finance
Published (Last): 18 January 2018
Pages: 179
PDF File Size: 17.6 Mb
ePub File Size: 12.45 Mb
ISBN: 177-1-79416-280-3
Downloads: 99897
Price: Free* [*Free Regsitration Required]
Uploader: Dait

The risk or severity of adverse effects can be increased when Raltitrexed is combined with Flucytosine.

Ancobon (flucytosine) dose, indications, adverse effects, interactions from

The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Flucytosine. The duration of treatment should be determined on an individual basis. The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Flucytosine.

The risk or severity of adverse effects can be increased when Flucytosine is combined with Afelimomab. Mechlorethamine The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Flucytosine. Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Flucytosine. Denosumab The risk or severity of adverse effects can be increased when Flucytosine is combined with Denosumab.

This should occur at least weekly in patients with renal insufficiency or blood dyscrasias.

  ANU SCRIPT MANAGER TELUGU APPLE KEYBOARD LAYOUT PDF

The risk or severity of infection can be increased when Rubella virus vaccine is combined with Flucytosine. Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Prescrining.

The risk or severity of bleeding can be increased when Sevoflurane is combined with Flucytosine. The cysteine conserved among DNA cytosine methylases is required for methyl transfer, but not for specific DNA binding.

The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Flucytosine. The risk or severity of adverse effects can be informstion when Flucytosine is combined with Belatacept. The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Flucytosine. Vincristine The risk or severity of adverse effects can be increased when Vincristine is combined with Flucytosine.

Japanese encephalitis virus strain sa antigen formaldehyde inactivated The therapeutic efficacy of Japanese encephalitis virus strain sa antigen formaldehyde inactivated can be decreased when used in combination with Flucytosine.

The risk or severity of adverse effects can be increased when Flucytosine is combined with Trilostane. For pediatric patients, a suspension may be made. Flucytosine in combination with amphotericin B is the preferred induction therapy for cryptococcal meningitis, severe pulmonary cryptococcosis, and cryptococcemia.

PDR Search

Accumulation of flucytosine in prescribibg fluid has been observed. The therapeutic efficacy of Hepatitis B Vaccine Recombinant can be decreased when used in combination with Flucytosine.

  COMMENT OBELIX EST TOMBE DANS LA MARMITE PDF

Dimethyl fumarate The risk or severity of adverse effects can be increased when Flucytosine is combined with Dimethyl fumarate. The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flucytosine. Only a small proportion of flucytosine is metabolised. The risk or severity of adverse effects can be increased when Flucytosine is combined with Tepoxalin. Tofacitinib Flucytosine may increase the immunosuppressive activities of Tofacitinib.

Flucytosine is a fluorinated pyrimidine derivative. Briakinumab The risk or severity of adverse effects can be increased when Flucytosine is combined with Briakinumab.

Brivudine, sorivudine and analogues are potent inhibitors of DPD, a fluorouracil metabolising enzyme see section 4.

The risk or severity of adverse effects can be increased when Flucytosine is combined with Golimumab. Bemiparin The risk or severity of bleeding can be increased when Bemiparin is combined with Flucytosine. Mometasone furoate The risk or severity of adverse effects can be increased when Flucytosine is combined with Mometasone furoate. The risk or severity of bleeding can be increased when Flucytosine is combined with Diphenadione. The therapeutic efficacy of Bacillus calmette-guerin substrain danish live antigen can be decreased when used in combination with Flucytosine.